1 | 1.2 mg ZGN-440 for injectable suspension | - | - | - | - | 1件: 193 193 💬 |
2 | 1.8 mg ZGN-440 for injectable suspension | - | - | - | - | 1件: 193 193 💬 |
3 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬 | - | - | 21件: 6 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 💬 |
4 | Acomplia | 1件: Rimonabant Rimonabant | 1件: Rimonabant
Rimonabant
💬 | 1件: CNR1 CNR1 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 193 193 💬 |
5 | ACOMPLIA 20 mg film-coated tablets | 1件: Rimonabant Rimonabant | 1件: Rimonabant
Rimonabant
💬 | 1件: CNR1 CNR1 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 193 193 💬 |
6 | Acylated and unacylated ghrelin dosages | 1件: Lenomorelin Lenomorelin | - | - | - | 3件: 193 193, 201, 202 💬 |
7 | Air | - | - | - | - | 3件: 85 85, 97, 193 💬 |
8 | ANASTROZOLE | 1件: Anastrozole Anastrozole | 1件: Anastrozole
Anastrozole
💬 | 1件: CYP19A1 CYP19A1 💬 | 3件: Metabolic pathways Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | 3件: 78 78, 86, 193 💬 |
9 | AZP-531 | - | - | - | - | 1件: 193 193 💬 |
10 | B. lactis B94 | - | - | - | - | 1件: 193 193 💬 |
11 | Beloranib | 1件: Beloranib Beloranib | - | - | - | 1件: 193 193 💬 |
12 | Byetta | 1件: Exenatide Exenatide | 1件: Exenatide
Exenatide
💬 | 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 6 6, 78, 193 💬 |
13 | Cannabidiol | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 18件: 6 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 |
14 | Cannabidiol Oral Solution | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 4件: 140 140, 144, 145, 193 💬 |
15 | CBDV | 1件: Cannabidivarin Cannabidivarin | - | - | - | 1件: 193 193 💬 |
16 | CBDV Compound | 1件: Cannabidivarin Cannabidivarin | - | - | - | 1件: 193 193 💬 |
17 | Chloride | 1件: Chloride ion Chloride ion | - | - | - | 28件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 💬 |
18 | Choline | 1件: Choline Choline | 1件: Choline
Choline
💬 | - | - | 4件: 93 93, 171, 193, 299 💬 |
19 | CSTI-500 | - | - | - | - | 1件: 193 193 💬 |
20 | D.3.2 Product code where applicable13: | - | - | - | - | 1件: 193 193 💬 |
21 | DCCR | - | - | - | - | 1件: 193 193 💬 |
22 | Diazoxide | 1件: Diazoxide Diazoxide | 1件: Diazoxide
Diazoxide
💬 | 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 2件: 13 13, 193 💬 |
23 | DIAZOXIDE CHOLINE | 2件: Choline Choline, Diazoxide | 2件: Diazoxide
Diazoxide
,
Choline
💬 | 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 193 193 💬 |
24 | Diazoxide choline controlled-release tablet | 2件: Choline Choline, Diazoxide | 2件: Diazoxide
Diazoxide
,
Choline
💬 | 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 193 193 💬 |
25 | EU/1/06/362/003: 5µg (1 pen) | - | - | - | - | 1件: 193 193 💬 |
26 | Eutropin | - | - | - | - | 2件: 78 78, 193 💬 |
27 | EXENATIDE | 1件: Exenatide Exenatide | 1件: Exenatide
Exenatide
💬 | 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 6件: 6 6, 17, 72, 78, 193, 233 💬 |
28 | FE 992097 | - | - | - | - | 1件: 193 193 💬 |
29 | Fluimucil | - | - | - | - | 4件: 85 85, 94, 193, 298 💬 |
30 | Fluimucil (acetylcysteine) | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬 | - | - | 1件: 193 193 💬 |
31 | Follow-up study of the treated cohort | - | - | - | - | 1件: 193 193 💬 |
32 | GENOTONORM | - | - | - | - | 1件: 193 193 💬 |
33 | Genotonorm Miniquick 0,2 mg | - | - | - | - | 1件: 193 193 💬 |
34 | Genotropin | 1件: Somatotropin Somatotropin | - | - | - | 5件: 13 13, 78, 107, 187, 193 💬 |
35 | GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made. | 1件: Somatotropin Somatotropin | - | - | - | 1件: 193 193 💬 |
36 | Ghrelin | 1件: Lenomorelin Lenomorelin | - | - | - | 6件: 6 6, 78, 193, 201, 202, 299 💬 |
37 | GLWL-01 | - | - | - | - | 1件: 193 193 💬 |
38 | Gold | 1件: Gold Gold | - | - | - | 43件: 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 💬 |
39 | Growth hormone | 1件: Somatotropin Somatotropin | - | - | - | 14件: 2 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 276, 299 💬 |
40 | Growth hormone (Genotonorm® or Omnitrope®) | 1件: Somatotropin Somatotropin | - | - | - | 2件: 78 78, 193 💬 |
41 | Guanfacine | 1件: Guanfacine Guanfacine | 1件: Guanfacine
Guanfacine
💬 | 1件: ADRA2A ADRA2A 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 193 193 💬 |
42 | Guanfacine Extended Release | 1件: Guanfacine Guanfacine | 1件: Guanfacine
Guanfacine
💬 | 1件: ADRA2A ADRA2A 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 193 193 💬 |
43 | Guanfacine extended release (GXR) | 1件: Guanfacine Guanfacine | 1件: Guanfacine
Guanfacine
💬 | 1件: ADRA2A ADRA2A 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 193 193 💬 |
44 | H01BB02 | - | - | - | - | 1件: 193 193 💬 |
45 | Human Growth Hormone | 1件: Somatotropin Somatotropin | - | - | - | 5件: 78 78, 187, 193, 265, 276 💬 |
46 | Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten | 1件: Somatotropin Somatotropin | - | - | - | 1件: 193 193 💬 |
47 | INN Not yet proposed | - | - | - | - | 1件: 193 193 💬 |
48 | Intranasal oxytocin | 1件: Oxytocin Oxytocin | 1件: Oxytocin
Oxytocin
💬 | 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 2件: 127 127, 193 💬 |
49 | Intranasal Oxytocin (IN-OXT) | 1件: Oxytocin Oxytocin | 1件: Oxytocin
Oxytocin
💬 | 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 1件: 193 193 💬 |
50 | Liraglutide | 1件: Liraglutide Liraglutide | 1件: Liraglutide
Liraglutide
💬 | 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 6 6, 75, 193 💬 |
51 | Livoletide | 1件: Livoletide Livoletide | - | - | - | 1件: 193 193 💬 |
52 | Medical air | 2件: Medical air Medical air, Oxygen | 1件: Oxygen
Oxygen
💬 | - | - | 3件: 85 85, 86, 193 💬 |
53 | Medical Air vs Oxygen | 2件: Medical air Medical air, Oxygen | 1件: Oxygen
Oxygen
💬 | - | - | 1件: 193 193 💬 |
54 | Metoprolol | 1件: Metoprolol Metoprolol | 1件: Metoprolol
Metoprolol
💬 | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 17 17, 57, 58, 113, 193, 226 💬 |
55 | Metoprolol succinate | 1件: Metoprolol Metoprolol | 1件: Metoprolol
Metoprolol
💬 | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 57 57, 58, 113, 193 💬 |
56 | METOPROLOL SUCCINATE (PH. EUR.) | 1件: Metoprolol Metoprolol | 1件: Metoprolol
Metoprolol
💬 | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 193 193 💬 |
57 | Metoprololsuccinat Orion 25mg | - | - | - | - | 1件: 193 193 💬 |
58 | Metoprololsuccinat ”Orion” 25mg | - | - | - | - | 1件: 193 193 💬 |
59 | NBT-NM108 | - | - | - | - | 1件: 193 193 💬 |
60 | Norditropin SimpleXx | 1件: Somatotropin Somatotropin | - | - | - | 5件: 3 3, 78, 107, 193, 195 💬 |
61 | Nutropin AQ | - | - | - | - | 4件: 78 78, 134, 193, 299 💬 |
62 | Octreotide | 1件: Octreotide Octreotide | 1件: Octreotide
Octreotide
💬 | 1件: SSTR2 SSTR2 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 7件: 67 67, 75, 84, 85, 89, 193, 227 💬 |
63 | OMNITROPE | 1件: Somatotropin Somatotropin | - | - | - | 2件: 78 78, 193 💬 |
64 | OSSITOCINA | - | - | - | - | 1件: 193 193 💬 |
65 | OT | - | - | - | - | 1件: 193 193 💬 |
66 | Oxygen | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
💬 | - | - | 13件: 6 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330 💬 |
67 | Oxytocin | 1件: Oxytocin Oxytocin | 1件: Oxytocin
Oxytocin
💬 | 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 7件: 6 6, 72, 127, 168, 193, 206, 226 💬 |
68 | Oxytocin (OXT) continuous | 1件: Oxytocin Oxytocin | 1件: Oxytocin
Oxytocin
💬 | 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 1件: 193 193 💬 |
69 | Oxytocin nasal spray | 1件: Oxytocin Oxytocin | 1件: Oxytocin
Oxytocin
💬 | 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 2件: 72 72, 193 💬 |
70 | Physiological serum (Sodium chloride) | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬 | - | - | 1件: 193 193 💬 |
71 | Pitolisant | 1件: Pitolisant Pitolisant | 1件: Pitolisant
Pitolisant
💬 | 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 113, 193 💬 |
72 | Pitolisant oral tablets | 1件: Pitolisant Pitolisant | 1件: Pitolisant
Pitolisant
💬 | 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 193 193 💬 |
73 | Probiotic | - | - | - | - | 8件: 2 2, 6, 93, 96, 97, 193, 266, 299 💬 |
74 | R05CB01 | - | - | - | - | 1件: 193 193 💬 |
75 | RAD011 | - | - | - | - | 1件: 193 193 💬 |
76 | Rapamycin | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬 | 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 18件: 15 15, 34, 35, 46, 49, 51, 53, 60, 61, 67, 86, 89, 96, 157, 158, 193, 256, 279 💬 |
77 | RECOMBINANT HUMAN GROWTH HORMON | - | - | - | - | 1件: 193 193 💬 |
78 | RECOMBINANT HUMAN GROWTH HORMONE | 1件: Somatotropin Somatotropin | - | - | - | 4件: 78 78, 193, 265, 276 💬 |
79 | Recombinant Human Growth Hormone (rhGH) Injection | 1件: Somatotropin Somatotropin | - | - | - | 1件: 193 193 💬 |
80 | Recombinant Somatropin | 1件: Somatotropin Somatotropin | - | - | - | 1件: 193 193 💬 |
81 | RGH-706 | - | - | - | - | 1件: 193 193 💬 |
82 | RhGH | 1件: Somatotropin Somatotropin | - | - | - | 6件: 76 76, 78, 96, 193, 246, 337 💬 |
83 | Rimonabant | 1件: Rimonabant Rimonabant | 1件: Rimonabant
Rimonabant
💬 | 1件: CNR1 CNR1 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 193 193 💬 |
84 | RM-493 | - | - | - | - | 2件: 193 193, 202 💬 |
85 | Sandostatin LAR | 1件: Octreotide Octreotide | 1件: Octreotide
Octreotide
💬 | 1件: SSTR2 SSTR2 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 4件: 67 67, 84, 193, 227 💬 |
86 | Saxenda | 1件: Liraglutide Liraglutide | 1件: Liraglutide
Liraglutide
💬 | 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 193 193 💬 |
87 | Sodium chloride | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬 | - | - | 20件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 💬 |
88 | Somatropin | 1件: Somatotropin Somatotropin | - | - | - | 19件: 2 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 💬 |
89 | Somatropin - adult cohort | 1件: Somatotropin Somatotropin | - | - | - | 1件: 193 193 💬 |
90 | Somatropin - GH naïve pediatric cohort | 1件: Somatotropin Somatotropin | - | - | - | 1件: 193 193 💬 |
91 | Somatropin - GH treated cohort | 1件: Somatotropin Somatotropin | - | - | - | 1件: 193 193 💬 |
92 | Subcutaneous Beloranib in Suspension | 1件: Beloranib Beloranib | - | - | - | 1件: 193 193 💬 |
93 | Syntocinon | 1件: Oxytocin Oxytocin | 1件: Oxytocin
Oxytocin
💬 | 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 127, 193 💬 |
94 | Syntocinon nasal spray | 1件: Oxytocin Oxytocin | 1件: Oxytocin
Oxytocin
💬 | 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 1件: 193 193 💬 |
95 | Syntocinon®/- Spray | 1件: Oxytocin Oxytocin | 1件: Oxytocin
Oxytocin
💬 | 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 1件: 193 193 💬 |
96 | Tesofensine | 1件: Tesofensine Tesofensine | - | - | - | 2件: 6 6, 193 💬 |
97 | TESOFENSINE CITRATE | 1件: Tesofensine Tesofensine | - | - | - | 1件: 193 193 💬 |
98 | Tesofensine/Metoprolol | 2件: Metoprolol Metoprolol, Tesofensine | 1件: Metoprolol
Metoprolol
💬 | 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 193 193 💬 |
99 | Tesomet | - | - | - | - | 1件: 193 193 💬 |
100 | TOPIRAMATE | 1件: Topiramate Topiramate | 1件: Topiramate
Topiramate
💬 | 36件: CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 53件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 6 6, 97, 140, 144, 156, 193 💬 |
101 | ZGN-440 | - | - | - | - | 1件: 193 193 💬 |
102 | ZGN-440 for Injectable Suspension | - | - | - | - | 1件: 193 193 💬 |
103 | ZGN-440 sterile diluent | - | - | - | - | 1件: 193 193 💬 |